Video Experimental Relacionado

Updated: May 5, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

Papel fundamental de la oligomerización en los trastornos neurodegenerativos por poliglutamina expandida

Ivelisse Sánchez¹, Christian Mahlke, Junying Yuan

¹Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

|January 24, 2003

Resumen

El rojo del Congo inhibe la oligomerización de la poliglutamina (polyQ), previniendo la neurodegeneración en el Huntington.

Área de la Ciencia:

La neurociencia es la neurociencia.
Biología Molecular Biología Molecular
La bioquímica es la bioquímica.

Sus antecedentes:

La expansión repetida de la poliglutamina (polyQ) causa trastornos neurodegenerativos.
Los agregados de PolyQ están implicados en la patogénesis de enfermedades, pero su contribución directa es objeto de debate.
Las formas oligoméricas de poliQ se proponen como especies tóxicas.

Objetivo del estudio:

Para investigar el papel de la oligomerización de la poliglutamina en la neurodegeneración.
Evaluar el potencial del rojo del Congo para inhibir la oligomerización del polyQ y sus efectos terapéuticos.

Principales métodos:

Utilizó el rojo del Congo, un colorante azoico conocido por unir hojas beta.
Efectos evaluados en la oligomerización de polyQ in vitro e in vivo.
Se administró el rojo del Congo a un modelo de ratón transgénico de la enfermedad de Huntington.

Principales resultados:

El rojo del Congo inhibió la oligomerización de la poliglutamina, evitando el agotamiento del ATP y la activación de la caspasa.
El tratamiento promovió el aclaramiento de las repeticiones expandidas de poliglutamina.
La administración de rojo del Congo mejoró la supervivencia, el peso y la función motora en ratones con enfermedad de Huntington.

Conclusiones:

La oligomerización de la poliglutamina es crítica para la neurotoxicidad crónica.
La inhibición de la oligomerización de la poliglutamina con el rojo del Congo demuestra un potencial terapéutico para la enfermedad de Huntington y trastornos relacionados.

Más Videos Relacionados

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans

Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans

Published on: December 17, 2021

Videos de Conceptos Relacionados

Protein Folding

Protein Folding

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

Protein Folding Quality Check in the RER

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...